Search alternatives:
19 a » 19 _ (Expand Search)
decrease » increase (Expand Search)
Showing 61 - 80 results of 1,123 for search '(( 50 pp decrease ) OR ((((( 10 i decrease ) OR ( 19 a decrease ))) OR ( 5 ng decrease ))))', query time: 0.20s Refine Results
  1. 61

    Soluble ACE2 and angiotensin II levels are modulated in hypertensive COVID-19 patients treated with different antihypertension drugs by Mohamed A. Elrayess (21398687)

    Published 2022
    “…ACE2 levels increase with disease severity in patients taking an ARB (<i>p</i> = 0.01), patients taking ACEi, the degree of disease severity was associated with a decrease in angiotensin II. …”
  2. 62
  3. 63
  4. 64

    One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes by Goran Petrovski (129836)

    Published 2022
    “…The participants used the sensor 88.4 ± 6.5% of the time with Auto Mode usage 85.6 ± 7.4% during 12 months of HCL system use. HbA1c decreased from 8.2 ± 1.4% (66 ± 15.3 mmol/mol) at baseline, to 6.7 ± 0.5% (50 ± 5.5 mmol/mol) at 3 months (p = 0.02) and remained stable to 7.1 ± 0.6 (54 ± 6.6 mmol/mol) at 12 months (p = 0.02). …”
  5. 65
  6. 66
  7. 67

    Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes by Abu Saleh Md Moin (6189512)

    Published 2019
    “…Dedifferentiation is well characterized by the decrease in expression of key β cell markers such as genes encoding major transcription factors, e.g., MafA, NeuroD1, Nkx6.1, and Foxo1, and an increase in atypical or “disallowed” genes for β cells such as lactate dehydrogenase, monocarboxylate transporter MCT1, or progenitor cell genes (Neurog3, Pax4, or Sox9). …”
  8. 68

    The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 by Christopher J L Murray (18278781)

    Published 2022
    “…</p><h3>Findings</h3><p dir="ltr">Globally, in 2019, the risk factors included in this analysis accounted for 4·45 million (95% uncertainty interval 4·01–4·94) deaths and 105 million (95·0–116) DALYs for both sexes combined, representing 44·4% (41·3–48·4) of all cancer deaths and 42·0% (39·1–45·6) of all DALYs. There were 2·88 million (2·60–3·18) risk-attributable cancer deaths in males (50·6% [47·8–54·1] of all male cancer deaths) and 1·58 million (1·36–1·84) risk-attributable cancer deaths in females (36·3% [32·5–41·3] of all female cancer deaths). …”
  9. 69

    miRNA-dependent regulation of STIM1 expression in breast cancer by Rashmi P. Kulkarni (18618634)

    Published 2019
    “…Consistently, overexpression of Ago2 results in decreased STIM1 protein levels in MDA-MB-231 cells. …”
  10. 70

    COVID-19 biomarkers for severity mapped to polycystic ovary syndrome by Abu Saleh Md Moin (6189512)

    Published 2020
    “…</p><p dir="ltr">Correction: COVID-19 biomarkers for severity mapped to polycystic ovary syndrome: <a href="https://doi.org/10.1186/s12967-021-02782-w" rel="noreferrer" target="_blank">https://doi.org/10.1186/s12967-021-02782-w</a>, published online 15 March 2021.…”
  11. 71
  12. 72

    Klotho overexpression protects human cortical neurons from β-amyloid induced neuronal toxicity by Mohammed R. Shaker (10316180)

    Published 2025
    “…Our data reveal that upregulation of <i>KLOTHO</i> significantly reduced β-amyloid-induced neuronal degeneration and apoptosis, as evidenced by decreased cleaved caspase-3 expression and preservation of axonal integrity. …”
  13. 73
  14. 74
  15. 75

    Ambulatory general urgent clinic: an initiative at the time of COVID-19 pandemic by Abdullah Al-Hothi (18505290)

    Published 2024
    “…Long waiting time to get an appointment is a universal challenge that increased during the COVID-19 pandemic. …”
  16. 76
  17. 77

    COVID-19 and Anemia: What Do We Know So Far? by Luai Abu-Ismail (10712857)

    Published 2023
    “…The existing literature has a suspected link between anemia and severe COVID-19 cases. …”
  18. 78

    Nebulized fentanyl for respiratory symptoms in patients with COVID-19 (ventanyl trial) by Nissar Shaikh (11659441)

    Published 2022
    “…The proposed theory behind that was that fentanyl decreased the rate of spontaneous respiratory rate, diminished the brain stem chemoreceptor response to hypoxia and hypercarbia, in addition to exhibiting a modulating effect on the brain stem. …”
  19. 79
  20. 80